C-Src tyrosine Kinase (CSK) (Middle Region) Peptide
-
- Antigène Tous les produits CSK
- CSK (C-Src tyrosine Kinase (CSK))
- Protein Region
- Middle Region
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- SEDNVAKVSD FGLTKEASST QDTGKLPVKW TAPEALREKK FSTKSDVWSF
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CSK Antibody(ARP52042_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- CSK (C-Src tyrosine Kinase (CSK))
- Synonymes
- AW212630 Peptide, C-terminal Src kinase Peptide, c-src tyrosine kinase Peptide, CSK, non-receptor tyrosine kinase Peptide, CSK Peptide, Csk Peptide
- Sujet
-
CSK specifically phosphorylates 'Tyr-504' on LCK, which acts as a negative regulatory site.CSK can also act on the LYN and FYN kinases.
Alias Symbols: MGC117393
Protein Interaction Partner: CDH5,CSK,IGF1R,INSR,RGS16,ADRB2,ARRB1,CAV1,CD247,CD44,CDH5,CREBBP,CSK,DAB2,DOK1,DOK3,FGR,FYN,G3BP1,GJA1,GSN,HCK,HNRNPK,IGF1R,INSR,LAIR1,LCK,LYN,MAPK15,PAG1,PECAM1,PLD2,PRKACA,PTK2,PTPN12,PTPN18,PTPN22,PXN,RASA1,RGS16,SDC3,SHC1,SIT1,SRC,TLR3,ARRB1,CAV1,CBL
Protein Size: 450 - Poids moléculaire
- 51 kDa
- ID gène
- 1445
- NCBI Accession
- NM_004383, NP_004374
- UniProt
- P41240
-